|
Home Page
About Us
Investors
Inventors
Portfolio
3DR Laboratories, LLC
AllTranz Inc.
ApoVax, Inc.
Edumedics, LLC
EndoProtech, Inc.
Eyevation, LLC
Gnarus Systems, Inc.
ImmunoTheragnostics Incorporated
Intrepid Bioinformatics, Inc.
PGxl Laboratories, LLC
RhinoCyte, Inc.
TrackFive Diagnostics, Inc.
Contact Us
Privacy Policy
|
|
|
|
Portfolio - Gnarus Systems, Inc.
| Incorporated: |
|
May 2009
|
| Contact: |
|
Andrew Steen
|
Scientific Founders:
|
|
Albert R. Cunningham, Ph.D.
Suzanne L. Cunningham
|
| Description: |
|
Gnarus Systems, Inc. will offer cat-SAR®, a peer-reviewed in silico toxicity prediction expert system, to the global chemical industry in a web-based software as a service [SaaS] version.
Albert R. Cunningham, Ph.D., Founder and President, has been involved in developing computer-based toxicology prediction models since 1993.
cat-SAR® is a reliable and cost effective means to predict a range of mammalian toxicological endpoints, including prediction of non-genotoxic carcinogens.
|
| Web Site: |
|
http://www.gnarussystems.com/ |
|
|
